Recent News

• 06.10.2025 - Highlights from Digestive Disease Week 2025
• 06.06.2025 - ASCO 2025 Highlights | Oncology Innovation in Motion
• 06.04.2025 - Strengthened Logistics Capabilities to Advance Global Trials
• 05.21.2025 - [Upcoming Webinar] Advancing Atherosclerotic Cardiovascular Disease Trials Through Innovative Imaging Endpoints
• 05.19.2025 - Women’s Health Month 2025 Feature: Clinical Strategy for UTI Drug Development
• 05.16.2025 - Highlights from ESCMID Global 2025 and a Look Ahead into the Next Wave of Innovations
• 05.16.2025 - Medpace Holdings, Inc. Annual Meeting of Stockholders
• 04.29.2025 - [Upcoming Webinar] Shaping the Future of Rheumatology Trials: Operational Strategies, Industry Trends, and Breakthroughs in Cell & Gene Therapies
• 04.22.2025 - Q1 2025 Medpace Holdings, Inc. Earnings Conference Call
• 04.22.2025 - Q1 2025 Medpace Holdings, Inc. Earnings Conference Call

Recent Filings

• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 8-K Current report
• 04.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2025 - 144 Report of proposed sale of securities
• 04.22.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]